Event Details
Piramal Pharma Limited will host a conference call for investors and analysts on 28th October 2026 from 10:00 AM to 10:45 AM (IST) to discuss its Q2 and H1 FY2027 financial results.
Conference Call Access Details
Global dial-in numbers have been provided for participants:
- India: +91 22 6280 1461 / +91 22 7115 8320 (Primary Number) or toll-free 1 800 120 1221 at 10:00 AM IST
- USA: Toll-free 1-866-746-2133 at 12:30 AM Eastern Time (New York)
- UK: Toll-free 0-808-101-1573 at 04:30 AM London Time
- Singapore: Toll-free 800-101-2045 at 12:30 PM Singapore Time
- Hong Kong: Toll-free 800-964-448 at 12:30 PM Hong Kong Time
Participants can use the Express Join with Diamond Pass™ feature by prior registration through a provided link to reduce wait time.
Company Background Information
Piramal Pharma Limited (PPL) operates with:
- 17 global development and manufacturing facilities
- Global distribution network in over 100 countries
- Business segments include:
- Piramal Pharma Solutions (PPS): Integrated contract development and manufacturing organization
- Piramal Critical Care (PCC): Complex hospital generics business
- Piramal Consumer Healthcare: Over-the-counter consumer and wellness products
- Associate company: Abbvie Therapeutics India Private Limited, a joint venture between Abbvie and PPL, which is a market leader in ophthalmology therapy in the Indian pharma market